12:00 AM
Apr 01, 2013
 |  BC Week In Review  |  Company News  |  Deals

PKU International Healthcare Group, Shanghai Medicilon Inc., SK Biopharmaceuticals deal

SK and CRO Medicilon amended a 2011 deal. Under the amended deal, PKU's Southwest Synthetic Pharmaceuticals and PKUCare Pharmaceutical R&D Center subsidiaries will join...

Read the full 98 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >